how glp-1 works for weight loss Study finds receptor agonists target fat over muscle Medically Supervised GLP-1 Weight Loss

10.1073/pnas.2415815121

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and GLP-1/GIP dual agonists, collectively referred to as GLP-1-based medications, have transformed the treatment landscape for obesity and cardiometabolic disease

FAQ What Else Can We Help You With?

Patients who prioritize portion control, nutritious meals, and regular exercise reach their goals faster than those who simply rely on the effects of the medication

Safety and Tolerability Overall, GLP-1 RAs are well tolerated, with GI symptoms being the most common adverse events (AEs), such as nausea, vomiting, diarrhoea, constipation and abdominal pain